Wellpoint: Oppenheimer Funds' Largest Healthcare Stock Holding in Q3 Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Allergan Inc. (NYSE:AGN): On 06/30/2011, Oppenheimer Funds, ... |
